Replies to post #124856 on Biotech Values

[DewDiligence]

…will need to do at least 2-3 more phase-2 studies before IDX184 can move into late stage testing.

Why do you think they will have to run so many phase-2 studies?

p.s. This is the listing for the phase-2b in progress:
http://www.clinicaltrials.gov/ct2/show/NCT01371604 .